Zentalis Pharmaceuticals announces inducement grants under Nasdaq Listing Rule 5635(C)(4)
ZNTL•Zentalis Pharmaceuticals announced inducement grants under Nasdaq Listing Rule 5635(C)(4).
Related News
Palantir expects quarterly revenue above estimates on strong AI demand
PLTR•
Apple slips on Q1 gross margin, services growth forecast
AAPL•
Axe Compute appoints Christopher Miglino as board chair effective Nov. 1, 2026
AGPU•
Saba Capital Management reports acquisition of $787,182.63 in Mexico Equity and Income Fund common shares
MXE•
Neurocrine rises after raising 2026 sales forecast for movement-disorder drug
NBIX•